Increased cytotoxicity and bystander effect of 5-fluorouracil and 5′-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase

被引:84
作者
Evrard, A
Cuq, P
Ciccolini, J
Vian, L
Cano, JP
机构
[1] Fac Pharm Montpellier, Lab Toxicol Medicament, F-34060 Montpellier 02, France
[2] Lab Toxicocinet & Pharmacocinet, F-13385 Marseille, France
关键词
cancer gene therapy; thymidine phosphorylase; 5-FU; 5 '-DFUR; bystander effect;
D O I
10.1038/sj.bjc.6690589
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5-Fluorouracil (5-FU) and 5'-deoxy-5-fluorouridine (5'-DFUR), a prodrug of 5-FU, are anticancer agents activated by thymidine phosphorylase (TP). Transfecting the human TP cDNA into cancer cells in order to sensitize them to these pyrimidine antimetabolites may he an important approach in human cancer gene therapy research. In this study, an expression vector containing the human TP cDNA (pcTP5) was transfected into LS174T human colon carcinoma cells. Eight stable transfectants were randomly selected and analysed. The cytotoxic effects of 5-FU and 5'-DFUR were higher in TP;transfected cells as compared to wild-type cells. The maximal decreases in the IC50 were 80-fold for 5-FU and 40-fold for 5'-DFUR. The increase in sensitivity to these pyrimidines of TP-transfected cells significantly correlated with the increase in both TP activity and TP expression. Transfected clone LS174T-c2 but not wild-type cells exhibited formation of [H-3]FdUMP from [H-3]5-FU. in addition the LS174T-c2 clone enhanced the cytotoxic effect of 5'-DFUR, but also that of 5-FU, towards co-cultured parental cells. For both anti-cancer agents, this bystander effect did not require cell-cell contact. These results show that both 5-FU or 5'-DFUR could be used together with a TP-suicide Vector in cancer gene therapy.
引用
收藏
页码:1726 / 1733
页数:8
相关论文
共 48 条
[1]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[2]   EFFECT OF HERPES-SIMPLEX VIRUS THYMIDINE KINASE EXPRESSION LEVELS ON GANCICLOVIR-MEDIATED CYTOTOXICITY AND THE BESTANDER EFFECT [J].
CHEN, CY ;
CHANG, YN ;
RYAN, P ;
LINSCOTT, M ;
MCGARRITY, GJ ;
CHIANG, YL .
HUMAN GENE THERAPY, 1995, 6 (11) :1467-1476
[3]  
CHEN L, 1995, CANCER RES, V55, P581
[4]  
CHU E, 1990, MOL PHARMACOL, V38, P410
[5]  
Cohen AM, 1993, Cancer: principles and practice o f oncology, P929
[6]   Bystander effects of different enzyme-prodrug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes [J].
Denning, C ;
Pitts, JD .
HUMAN GENE THERAPY, 1997, 8 (15) :1825-1835
[7]   CATABOLISM OF THYMIDINE IN HUMAN-BLOOD PLATELETS PURIFICATION AND PROPERTIES OF THYMIDINE PHOSPHORYLASE [J].
DESGRANGES, C ;
RAZAKA, G ;
RABAUD, M ;
BRICAUD, H .
BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 654 (02) :211-218
[8]  
ELIAS L, 1988, CANCER RES, V48, P4868
[9]  
Evrard A, 1999, INT J CANCER, V80, P465, DOI 10.1002/(SICI)1097-0215(19990129)80:3<465::AID-IJC21>3.0.CO
[10]  
2-6